Nanotechnology and Antivirus Nanomaterials for Combating COVID-19
Strategies against SARS-CoV-2 Variants in the Post-pandemic Era
- 1st Edition - December 3, 2025
- Latest edition
- Editor: Jen-Tsung Chen
- Language: English
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advanc… Read more
Description
Description
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable resource for researchers, scientists, and professionals seeking a deeper understanding of nanotechnology's applications for preventing, diagnosing, and managing COVID-19.
Key features
Key features
- Highlights cutting-edge tools and recent applications of nanotechnology in the fight against SARS-CoV-2.
- Outlines the latest accomplishments in COVID-19 management through nanomaterial-based strategies.
- Presents up-to-date insights into the role of nanotechnology in the development of COVID-19 vaccines
Readership
Readership
Researchers and scientists in the fields of nanotechnology, materials science, and those engaged in nanotechnology-based applications and SARS-CoV-2 infections.
Table of contents
Table of contents
1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating coronavirus
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating coronavirus
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21.. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
Product details
Product details
- Edition: 1
- Latest edition
- Published: December 12, 2025
- Language: English
About the editor
About the editor
JC
Jen-Tsung Chen
Jen-Tsung Chen is a Professor of Cell Biology at the National University of Kaohsiung in Taiwan, where he teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. His research spans bioactive compounds, chromatography techniques, plant molecular biology, bioinformatics, systems pharmacology, and broader themes in biotechnological plant disease management, plant biotic stress responses, nanotechnology for combating pests and pathogens, ethnopharmacology, and systems biology. An active scholar, Dr. Chen serves on the editorial boards of several international journals and has guest‑edited numerous special issues. He has also authored and edited books with major international publishers on topics including drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR‑based genome editing, and artificial intelligence. Recognized for his scientific impact and editorial leadership, Dr. Chen was listed among Elsevier and Stanford University’s “World’s Top 2% Scientists” in 2023 and 2024 and received the Springer Nature Editor of Distinction Award in 2025.
Affiliations and expertise
Professor, Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Nanzih District, TaiwanView book on ScienceDirect
View book on ScienceDirect
Read Nanotechnology and Antivirus Nanomaterials for Combating COVID-19 on ScienceDirect